AvKARE recalls

AvKARE has 57 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 4 Mar 2026. 22 are still ongoing. 3 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls57since 2015

Last 12 months3reported

Class I24% of total

Ongoing22latest 4 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 5 3Jan '25 2 0 0Apr 0 2 2Jul 0 2 1Oct 0 0 1Jan '26 0 1 0Apr 0 0 0Jul 0 0

Severity split

Class I 2 4%Class II 42 74%Class III 13 23%

Why avkare is recalled

Product types

Brands

By year

202624%
20251221%
2024611%
202347%
202212%
202112%
2020712%
20191221%
2018712%
201735%

Ongoing avkare recalls

22 active

Reported	Class	Recall	Company	Reason	Where
4 Mar 2026Drug	CLASS II	Amantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine Hcl	AvKARE	Potency & Assay	Nationwide
14 Jan 2026Drug	CLASS II	Rosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatin	AvKARE	Potency & Assay	Nationwide
15 Oct 2025Drug	CLASS II	Norgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl Estradiol	AvKARE	Other	Nationwide
17 Sep 2025Drug	CLASS II	chloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine Hydrochloride	AvKARE	Other	Nationwide
17 Sep 2025Drug	CLASS II	chloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine Hydrochloride	AvKARE	Other	Nationwide
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 2 mg recalled by AvKAREPitavastatin	AvKARE	Potency & Assay	Nationwide

All avkare recalls, newest first

57 total

Reported	Class	Recall	Company	Reason	Where
4 Mar 2026Drug	CLASS II	Amantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine Hcl	AvKARE	Potency & Assay	Nationwide
14 Jan 2026Drug	CLASS II	Rosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatin	AvKARE	Potency & Assay	Nationwide
15 Oct 2025Drug	CLASS II	Norgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl Estradiol	AvKARE	Other	Nationwide
17 Sep 2025Drug	CLASS II	chloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine Hydrochloride	AvKARE	Other	Nationwide
17 Sep 2025Drug	CLASS II	chloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine Hydrochloride	AvKARE	Other	Nationwide
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 2 mg recalled by AvKAREPitavastatin	AvKARE	Potency & Assay	Nationwide
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 1 mg recalled by AvKAREPitavastatin	AvKARE	Potency & Assay	Nationwide
18 Jun 2025Drug	CLASS II	Celecoxib Capsules, 200 mg Unit Dose recalled by AvKARECelecoxib	AvKARE	Hidden Drug Ingredients	Nationwide
18 Jun 2025Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg Unit Dose cards recalled by AvKAREChlorthalidone	AvKARE	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Silodosin Capsules, 8mg recalled by AvKARESilodosin	AvKARE	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.